Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARED: High Dose Vitamin D in COVID-19
NCT04411446Phase 4Completed
- Sponsor
- Vitamin D Study Group
- Start
- Aug 2020
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Vitamin D with Placebo (2 arms). Primary endpoints: Respiratory Sequential Organ Failure Assessment at 1 week and Need of a high dose of oxygen or mechanical ventilation at 30 days. Started Aug 2020; status: completed.
02
Drugs
vitamin d
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04411446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04411446.